Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics International Hires 1st Base as Agent in Parts of Asia

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian proteomics contract research organization Proteomics International said today it has hired 1st Base to be its exclusive agent in Singapore, Malaysia, Indonesia, and Thailand.

Together, the two firms will promote Proteomics International's analytical services for biological research and development for pharmaceutical, biotech, academic, and government entities, they said in a statement.

Financial terms of the deal were not disclosed.

Proteomics International has expertise in protein analysis and mass spectrometry, and received International Organization for Standardization accreditation from an Australian accreditation agency for its proteomics service lab in August.

Based in Singapore, 1st Base provides a range of customized services and products for firms in the Asia Pacific region.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.